These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32601799)

  • 1. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
    Liang JY; Xi SY; Shao Q; Yuan YF; Li BK; Zheng Y; Wang DS; Wu XJ; Ding PR; Chen G; Li LR; Wang FH; Wang ZQ; Pan ZZ; Xu RH; Li YH
    Cancer Immunol Immunother; 2020 Dec; 69(12):2623-2634. PubMed ID: 32601799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
    Wang Y; Lin HC; Huang MY; Shao Q; Wang ZQ; Wang FH; Yuan YF; Li BK; Wang DS; Ding PR; Chen G; Wu XJ; Lu ZH; Li LR; Pan ZZ; Sun P; Yan SM; Wan DS; Xu RH; Li YH
    Cancer Immunol Immunother; 2018 Mar; 67(3):435-444. PubMed ID: 29204700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
    Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
    Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of the Histopathological Growth Pattern and Tumor-Infiltrating Lymphocytes in Stratifying Survival After Hepatectomy for Colorectal Liver Metastases.
    Kanno H; Hisaka T; Fujiyoshi K; Akiba J; Hashimoto K; Fujita F; Akagi Y
    Ann Surg Oncol; 2023 May; 30(5):3139-3147. PubMed ID: 36520232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns.
    Nierop PMH; Galjart B; Höppener DJ; van der Stok EP; Coebergh van den Braak RRJ; Vermeulen PB; Grünhagen DJ; Verhoef C
    Clin Exp Metastasis; 2019 Apr; 36(2):109-118. PubMed ID: 30843120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer.
    Bohlok A; Tonneau C; Vankerckhove S; Craciun L; Lucidi V; Bouazza F; Hendlisz A; Van Laethem JL; Larsimont D; Vermeulen P; Donckier V; Demetter P
    Clin Exp Metastasis; 2023 Oct; 40(5):431-440. PubMed ID: 37453024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients.
    Zhang C; Wang X; Han J; Zhang R; Chen Z; Li Y; Ma X; Zhang G; Fan J; Chen J
    J Surg Oncol; 2021 Dec; 124(8):1431-1441. PubMed ID: 34406653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases.
    Bohlok A; Duran Derijckere I; Azema H; Lucidi V; Vankerckhove S; Hendlisz A; Van Laethem JL; Vierasu I; Goldman S; Flamen P; Larsimont D; Demetter P; Dirix L; Vermeulen P; Donckier V
    J Surg Oncol; 2021 May; 123(8):1773-1783. PubMed ID: 33751583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy.
    Filipe WF; Meyer YM; Buisman FE; van den Braak RRJC; Galjart B; Höppener DJ; Jarnagin WR; Kemeny NE; Kingham TP; Nierop PMH; van der Stok EP; Grünhagen DJ; Vermeulen PB; Groot Koerkamp B; Verhoef C; D'Angelica MI
    Ann Surg Oncol; 2023 Dec; 30(13):7996-8005. PubMed ID: 37782413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
    Zhang Y; Wang Y; Yuan Y; Qiu J; Qiu Y; He W; Zheng Y; Wang Z; Gu Y; Lu Z; Chen G; Ding P; Wu X; Pan Z; Wan D; Li Y; Xu R; Yuan Y; Li B
    World J Surg Oncol; 2020 May; 18(1):98. PubMed ID: 32423450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases.
    Meyer YM; Wilting SM; Kraan J; Olthof P; Vermeulen P; Martens J; Grünhagen DJ; Sleijfer S; Verhoef C
    Clin Exp Metastasis; 2023 Feb; 40(1):69-77. PubMed ID: 36326981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore.
    Baldin P; Van den Eynde M; Mlecnik B; Bindea G; Beniuga G; Carrasco J; Haicheur N; Marliot F; Lafontaine L; Fredriksen T; Lanthier N; Hubert C; Navez B; Huyghe N; Pagès F; Jouret-Mourin A; Galon J; Komuta M
    J Pathol Clin Res; 2021 Jan; 7(1):27-41. PubMed ID: 32902189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion of BLIMP-1
    Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
    Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection.
    Chen X; Du Z; Huang M; Wang D; Fong WP; Liang J; Fan L; Wang Y; Yang H; Chen Z; Hu M; Xu R; Li Y
    Cancer Immunol Immunother; 2022 Mar; 71(3):661-674. PubMed ID: 34322779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.
    Katz SC; Bamboat ZM; Maker AV; Shia J; Pillarisetty VG; Yopp AC; Hedvat CV; Gonen M; Jarnagin WR; Fong Y; D'Angelica MI; DeMatteo RP
    Ann Surg Oncol; 2013 Mar; 20(3):946-55. PubMed ID: 23010736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.